We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $41.6M invested in Atossa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
494% more call options, than puts
Call options by funds: $1M | Put options by funds: $169K
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
33% more capital invested
Capital invested by funds: $31.2M → $41.6M (+$10.4M)
12% more funds holding
Funds holding: 77 → 86 (+9)
0.06% more ownership
Funds ownership: 1.39% → 1.45% (+0.06%)
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
Holders
86
Holders Change
+9
Holders Change %
+11.69%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
21
Reduced
24
Closed
7
Calls
$1M
Puts
$169K
Net Calls
+$835K
Net Calls Change
+$173K
Top Buyers
| 1 |
Northern Trust
Chicago,
Illinois
|
+$925K |
| 2 |
BlackRock
New York
|
+$633K |
| 3 |
Goldman Sachs
New York
|
+$197K |
| 4 |
Barclays
London,
United Kingdom
|
+$166K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$151K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$324K |
| 2 |
Jane Street
New York
|
-$166K |
| 3 |
Bank of New York Mellon
New York
|
-$145K |
| 4 |
Mariner
Overland Park,
Kansas
|
-$126K |
| 5 |
Two Sigma Investments
New York
|
-$116K |
